This Article  • Full text  • PDF  • CME Course for This Article  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Quality of Life  • Oncology  • Head & Neck Cancer  • Neoplasms of Head & Neck  • Psychiatry  • Psychiatry, Other  • Alert me on articles by topic

David L. Ronis, PhD; Sonia A. Duffy, PhD, RN; Karen E. Fowler, MPH; Mumtaz J. Khan, MD; Jeffrey E. Terrell, MD

Arch Otolaryngol Head Neck Surg. 2008;134(3):241-248.

Objectives  To characterize and compare quality of life (QOL) in patients with head and neck cancer shortly before initial treatment and 1 year later and to study the predictors of changes in QOL over 1 year.

Design  Prospective cohort study.

Setting  Three otolaryngology clinics.

Patients  Three hundred sixteen patients having newly diagnosed squamous cell head and neck cancer.

Main Outcome Measure  Health-related QOL was assessed using the 36-item Short-Form Health Survey and a head and neck cancer–specific QOL scale.

Results  Over 1 year, QOL decreased for physical functioning measures and eating but improved for mental health QOL. Depression and smoking were major predictors of poor QOL at baseline. Major predictors of change in QOL from baseline to 1 year were treatment factors, especially feeding tube placement (9 scales), chemotherapy (3 scales), and radiation therapy (3 scales). Baseline smoking and depressive symptoms also remained significant predictors of several QOL scales at 1 year.

Conclusions  Health-related physical QOL tended to decline over 1 year and mental health QOL improved. The major predictors of change in QOL were treatment factors, smoking, and depressive symptoms. Physicians should alert patients to the relative effects on QOL one may experience with different treatments.

Author Affiliations: Veterans Affairs Ann Arbor Healthcare System, Ann Arbor Veterans Affairs Health Services Research & Development Service, Center of Excellence (Drs Ronis and Duffy and Ms Fowler), University of Michigan School of Nursing (Drs Ronis and Duffy), and Departments of Otolaryngology (Drs Duffy and Terrell) and Psychiatry (Dr Duffy), University of Michigan Medical School, Ann Arbor; and Henry Ford Health System, Department of Otolaryngology, Detroit, Michigan (Dr Khan).